Document Detail

Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway.
MedLine Citation:
PMID:  20735429     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND PURPOSE: Hydrogen sulphide (H(2)S) is a novel neuromodulator. The present study aimed to investigate the protective effect of H(2)S against cell injury induced by 6-hydroxydopamine (6-OHDA), a selective dopaminergic neurotoxin often used to establish a model of Parkinson's disease for studying the underlying mechanisms of this condition.
EXPERIMENTAL APPROACH: Cell viability in SH-SY5Y cells was measured using MTT assay. Western blot analysis and pharmacological manipulation were employed to study the signalling mechanisms.
KEY RESULTS: Treatment of SH-SY5Y cells with 6-OHDA (50-200 microM) for 12 h decreased cell viability. Exogenous application of NaHS (an H(2)S donor, 100-1000 microM) or overexpression of cystathionine beta-synthase (a predominant enzyme to produce endogenous H(2)S in SH-SY5Y cells) protected cells against 6-OHDA-induced cell apoptosis and death. Furthermore, NaHS reversed 6-OHDA-induced loss of tyrosine hydroxylase. Western blot analysis showed that NaHS reversed the down-regulation of PKCalpha, epsilon and Akt and the up-regulation of PKCdelta in 6-OHDA-treated cells. Blockade of PKCalpha with Gö6976 (2 microM), PKCepsilon with EAVSLKPT (200 microM) or PI3K with LY294002 (20 microM) reduced the protective effects of H(2)S. However, inhibition of PKCdelta with rottlerin (5 microM) failed to affect 6-OHDA-induced cell injury. These data suggest that the protective effects of NaHS mainly resulted from activation of PKCalpha, epsilon and PI3K/Akt pathway. In addition, NaHS-induced Akt phosphorylation was significantly attenuated by Gö6976 and EAVSLKPT, suggesting that the activation of Akt by NaHS is PKCalpha, epsilon-dependent.
CONCLUSIONS AND IMPLICATIONS: H(2)S protects SH-SY5Y cells against 6-OHDA-induced cell injury by activating the PKCalpha, epsilon/PI3K/Akt pathway.
Chi Xin Tiong; Ming Lu; Jin-Song Bian
Related Documents :
16868779 - Lack of antioxidative properties of vitamin c and pyruvate in cultured retinal pigment ...
12385779 - The role of oxidative stress in the ochratoxin a-mediated toxicity in proximal tubular ...
20691749 - Antioxidant and hepatoprotective activities of five eggplant varieties.
19187599 - Inducible nitric oxide synthase is involved in the oxidation stress induced by hiv-1 gp...
17292889 - The cytosolic ribonuclease inhibitor contributes to intracellular redox homeostasis.
15651079 - Stimulation of epstein-barr virus-infected human b cell growth by physiological concent...
6088569 - Efficiency of human rotavirus propagation in cell culture.
2139419 - Heterogeneity of the glucose transporter in malignant and suppressed hybrid cells.
20726799 - Lectin microarrays for glycomic analysis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of pharmacology     Volume:  161     ISSN:  1476-5381     ISO Abbreviation:  Br. J. Pharmacol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-25     Completed Date:  2011-01-04     Revised Date:  2013-05-28    
Medline Journal Info:
Nlm Unique ID:  7502536     Medline TA:  Br J Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  467-80     Citation Subset:  IM    
Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis / drug effects
Blotting, Western
Cell Culture Techniques
Cell Line, Tumor
Cell Survival / drug effects
Cystathionine beta-Synthase / genetics
Hydrogen Sulfide / metabolism,  pharmacology*
Neuroprotective Agents / pharmacology*
Oxidopamine / toxicity*
Phosphatidylinositol 3-Kinases / metabolism*
Protein Kinase C / metabolism*
Proto-Oncogene Proteins c-akt / metabolism*
Tyrosine 3-Monooxygenase / metabolism
Reg. No./Substance:
0/Neuroprotective Agents; 1199-18-4/Oxidopamine; 7783-06-4/Hydrogen Sulfide; EC 3-Monooxygenase; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC Proteins c-akt; EC Kinase C; EC beta-Synthase
Erratum In:
Br J Pharmacol. 2013 Apr;168(8):2011-2

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Histamine H1 receptor antagonist cetirizine impairs working memory processing speed, but not episodi...
Next Document:  Identification of endothelial cell-specific molecule-1 as a potential serum marker for colorectal ca...